Key result
Angptl2-deficient mice developed more severe lung fibrosis following bleomycin treatment compared to wild-type mice, suggesting ANGPTL2 plays a protective role against lung fibrosis.
Population
Wild-type and Angptl2 knockout (KO) mice
Comparison
Bleomycin treatment to induce interstitial… vs Wild-type mice treated with bleomycin
Design
Preclinical
Authors
Loading...
Hypothesis-generating for ANGPTL2 as fibrosis target; human studies needed before clinical consideration.
ANGPTL2 derived from lung epithelial cells and resident alveolar macrophages plays a protective role against bleomycin-induced lung fibrosis.
Motokawa et al. (2016) studied Bleomycin-induced interstitial pneumonia. Angptl2 deficiency vs. Wild-type was evaluated on Lung fibrosis severity. Angptl2-deficient mice developed more severe lung fibrosis following bleomycin treatment compared to wild-type mice, suggesting ANGPTL2 plays a protective role against lung fibrosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: